{"id":"NCT02333799","sponsor":"Global Alliance for TB Drug Development","briefTitle":"A Phase 3 Trial Assessing Safety and Efficacy of B-Pa-L in Participants With DR-TB","officialTitle":"A Phase 3 Open-label Trial Assessing the Safety and Efficacy of Bedaquiline Plus PA-824 Plus Linezolid in Participants With Pulmonary Infection of Either XDR-TB or Treatment Intolerant / Non-responsive MDR-TB.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-03","primaryCompletion":"2019-01-14","completion":"2020-08-03","firstPosted":"2015-01-07","resultsPosted":"2024-08-09","lastUpdate":"2025-09-08"},"enrollment":109,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Pulmonary Tuberculosis"],"interventions":[{"type":"DRUG","name":"Bedaquiline","otherNames":["B","TMC-207"]},{"type":"DRUG","name":"PA-824","otherNames":["Pa","pretomanid"]},{"type":"DRUG","name":"Linezolid","otherNames":["L","Lin"]}],"arms":[{"label":"Bedaquiline + PA-824 + Linezolid","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the efficacy, safety, tolerability and pharmacokinetics of bedaquiline plus PA-824 plus linezolid after 6 months of treatment (option for 9 months for participants who remain culture positive at month 4) in participants with either pulmonary extensively drug resistant tuberculosis (XDR-TB), treatment intolerant or non-responsive multi-drug resistant tuberculosis (MDR-TB).","primaryOutcome":{"measure":"Proportion of Treatment Failure (Unfavorable Outcome), Defined as Bacteriologic Failure or Relapse or Clinical Failure (Derived) Through Follow-up Until 6 Months After the End of Treatment.","timeFrame":"6 Months post End of Treatment","effectByArm":[{"arm":"Total","deltaMin":98,"sd":null},{"arm":"XDR-TB","deltaMin":63,"sd":null},{"arm":"TI/NR MDR-TB","deltaMin":35,"sd":null}],"pValues":[]},"eligibility":{"minAge":"14 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":3,"countries":["South Africa"]},"refs":{"pmids":["36804834","34604901","32130813"],"seeAlso":["http://www.tballiance.org"]},"adverseEventsSummary":{"seriousAny":{"events":13,"n":44},"commonTop":["Peripheral sensory neuropathy","Anaemia","Nausea","Vomiting","Headache"]}}